156 related articles for article (PubMed ID: 7638555)
1. Identification of the apo B-3500 mutation in the Norwegian population.
Leren TP; Rødningen OK; Tonstad S; Røsby O; Urdal P; Ose L
Scand J Clin Lab Invest; 1995 May; 55(3):217-21. PubMed ID: 7638555
[TBL] [Abstract][Full Text] [Related]
2. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK.
Wenham PR; Henderson BG; Penney MD; Ashby JP; Rae PW; Walker SW
Atherosclerosis; 1997 Mar; 129(2):185-92. PubMed ID: 9105560
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
[TBL] [Abstract][Full Text] [Related]
4. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
[TBL] [Abstract][Full Text] [Related]
5. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
[TBL] [Abstract][Full Text] [Related]
6. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
[TBL] [Abstract][Full Text] [Related]
7. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Miserez AR; Keller U
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
[TBL] [Abstract][Full Text] [Related]
8. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
Myant NB
Atherosclerosis; 1993 Dec; 104(1-2):1-18. PubMed ID: 8141833
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis in a small cohort of New Zealand patients originating from the United Kingdom demonstrates genetic heterogeneity in familial hypercholesterolemia.
Thiart R; Varret M; Lintott CJ; Scott RS; Loubser O; du Plessis L; de Villiers JN; Boileau C; Kotze MJ
Mol Cell Probes; 2000 Oct; 14(5):299-304. PubMed ID: 11040093
[TBL] [Abstract][Full Text] [Related]
10. Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia.
Giammanco A; Spina R; Fayer F; Barbagallo CM; Noto D; Cefalù AB; Averna MR
Intern Med J; 2021 Apr; 51(4):585-590. PubMed ID: 33890362
[TBL] [Abstract][Full Text] [Related]
11. Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.
Rubinsztein DC; Raal FJ; Seftel HC; Pilcher G; Coetzee GA; van der Westhuyzen DR
Arterioscler Thromb; 1993 Jul; 13(7):1076-81. PubMed ID: 8318509
[TBL] [Abstract][Full Text] [Related]
12. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
Morash B; Guernsey DL; Tan MH; Dempsey G; Nassar BA
Clin Biochem; 1994 Aug; 27(4):265-72. PubMed ID: 8001287
[TBL] [Abstract][Full Text] [Related]
13. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
14. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
15. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
Tai ES; Koay ES; Chan E; Seng TJ; Loh LM; Sethi SK; Tan CE
Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of familial hypercholesterolaemia in Norway.
Leren TP; Tonstad S; Gundersen KE; Bakken KS; Rødningen OK; Sundvold H; Ose L; Berg K
J Intern Med; 1997 Mar; 241(3):185-94. PubMed ID: 9104431
[TBL] [Abstract][Full Text] [Related]
17. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
Gaffney D; Forster L; Caslake MJ; Bedford D; Stewart JP; Stewart G; Wieringa G; Dominiczak M; Miller JP; Packard CJ
Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
[TBL] [Abstract][Full Text] [Related]
18. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
[TBL] [Abstract][Full Text] [Related]
19. Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia.
Rauh G; Keller C; Schuster H; Wolfram G; Zöllner N
Clin Investig; 1992 Jan; 70(1):77-84. PubMed ID: 1600334
[TBL] [Abstract][Full Text] [Related]
20. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]